You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Prevention and Outpatient Management of Febrile Neutropenia in Adult Cancer Patients: Clinical Practice Guideline

ID: GL-C50-27 Nov 2021
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Andrea Crespo, Leta Forbes, Kathy Vu, Daniela Gallo-Hershberg, Katherine Enright, Mona Abdallah, Michela Febbraro, Tiffany Gowanlock, Kardi Kennedy, Charles Lim, Sabrina Liu, Taylor Mackenzie, Jennifer Newton, Silvana Spadafora, Jordan Zeppieri

Guideline Objective

Optimal prevention and safe management of febrile neutropenia (FN) in the outpatient setting, when clinically appropriate, can help to keep vulnerable patients from experiencing severe complications requiring hospitalization. The objective of this guideline is to provide clinicians with updated recommendations for prevention of FN and new guidelines for the outpatient management of FN in adult cancer patients receiving systemic treatment in Ontario.

Patient Population

Cancer patients who are receiving myelosuppressive systemic treatment.

Intended Guideline Users

All health care providers involved in caring for cancer patients who are receiving myelosuppressive systemic treatment (oncologists/hematologists, nurses, pharmacists, emergency room clinicians, etc.).

pdf download Summary (PDF) (610.99 KB)
pdf download Full Report (PDF) (1021.99 KB)

Guideline-Based Clinical Tools